Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Journal of Environmental Pathology, Toxicology and Oncology
Fator do impacto: 1.241 FI de cinco anos: 1.349 SJR: 0.519 SNIP: 0.613 CiteScore™: 1.61

ISSN Imprimir: 0731-8898
ISSN On-line: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.v21.i1.80
7 pages

Detection of Human Papillomavirus DNA, Serum p53, and p53 Antibodies in Patients with Cervical Cancer

Ranbir C. Sobti
Department of Biotechnology, Panjab University, Chandigarh, India
Kamana Parashar
Department of Biotechnology, Panjab University, Chandigarh, India
Raminder Kaur
Department of Biotechnology, Panjab University, Chandigarh, India
Neena Capalash
Department of Biotechnology, Panjab University, Chandigarh, India

RESUMO

Human papillomavirus (HPV) was detected in 85% and 63.6% of patients with invasive cervical cancer and minor cervical abnormalities, respectively. HPV-16 was the dominant type in both groups of women. Because of the high oncogenic potential of HPV-16 and the greater chance of its persistence, a follow-up of cases with minor cervical abnormalities harboring HPV-16 is warranted in order to observe the progression of the lesion. As many as 61.5% of the cases with invasive cervical cancer were found to have higher levels of serum p53 protein than did healthy controls. None of the patients had antibodies against the overexpressed p53. This suggests that, even if mutated, the p53 protein may not be immuno-genic in all cases. An inverse relationship between the presence of HPV and the alteration in p53 expression was observed in 71.43% of the cases. This could mean the loss of p53 function as a result of either HPV-E6-mediated degradation or mutation in the p53 gene.


Articles with similar content:

Mental Adaptation to Mammary Cancer and VNTR Genetic Polymorphism of MAO-A
Neuropathological Diseases, Vol.2, 2013, issue 1
Tullio Giraldi, Giulia Schillani, Masa Jovic
Braf Mutations Are Associated With High Levels of Phosphorylated RKIP in Melanoma Cell Lines: Potential Prognostic Significance
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 2
S. Ekmekcioglu, Sara Huerta-Yepez, C. M. Rivera-Pazos, Elizabeth A. Grimm, Mario I. Vega, G. Antonio-Andres, G. Baay-Guzman
TRAF Family Member-Associated NF-KB Activator (TANK) Gene Polymorphism in Chronic Periodontitis and Peri-implantitis Patients
Journal of Long-Term Effects of Medical Implants, Vol.22, 2012, issue 2
Elahe Shams, Mahmood Tamizi, Mahdi Kadkhodazadeh, Ahmad Reza Ebadian, Reza Amid
Relationship between Topoisomerase II Alpha Overexpression and Prognosis in Chinese Gastric Cancer Patients
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 3
Binghe Xu, Fangchao Zheng, Feng Du, Jinhua Ma, Fei Ma, Ziyi Wang, Junhui Zhao, Shuyan Wang, Wei Ma, Li Dong, Guoshuang Shen, Yang Luo, Cunfang Shen, Jiuda Zhao, Xinfu Ma
The Oncogenic Role of Human Papillomavirus Proteins
Critical Reviews™ in Oncogenesis, Vol.7, 1996, issue 1-2
Miguel S. Barbosa